ClinVar Miner

Submissions for variant NM_000789.4(ACE):c.3689C>T (p.Ser1230Phe)

dbSNP: rs756742824
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000489498 SCV000577013 uncertain significance not provided 2017-04-12 criteria provided, single submitter clinical testing The c.3689 C>T variant in the ACE gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The c.3689 C>T variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). In-silico splice prediction models predict that c.3689 C>T may destroy the natural splice donor site in intron 24. However, in the absence of RNA/functional studies, the actual effect of the c.3689 C>T change in this individual is unknown. If c.3689 C>T does not alter splicing, it will result in the S1230F missense change. The c.3689 C>T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret c.3689 C>T as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.